These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2384581)

  • 1. Determination of the active metabolite of molsidomine in human plasma by reversed-phase high-performance liquid chromatography.
    Dutot C; Moreau J; Cordonnier P; Spreux-Varoquaux O; Klein C; Ostrowski J; Advenier C; Gärtner W; Pays M
    J Chromatogr; 1990 Jun; 528(2):435-46. PubMed ID: 2384581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of molsidomine and its active metabolite in human plasma using liquid chromatography with tandem mass spectrometric detection.
    Streel B; Ceccato A; Peerboom C; Zimmer C; Sibenaler R; Maes P
    J Chromatogr A; 1998 Sep; 819(1-2):113-23. PubMed ID: 9781417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of molsidomine and of its active metabolite, SIN-1 (or linsidomine), in the elderly.
    Spreux-Varoquaux O; Ulmer B; Cordonnier P; Forestier A; Pays M; Ducreuzet C; Advenier C
    Fundam Clin Pharmacol; 1991; 5(6):549-56. PubMed ID: 1955198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the lower esophageal sphincter pressure after oral molsidomine by sydnonimine plasma concentrations.
    Stoschus B; Fernandez I; Heller J; Neubrand M; Sauerbruch T
    Hepatogastroenterology; 1999; 46(26):933-7. PubMed ID: 10370642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of amosulalol in human plasma using solid-phase extraction combined with liquid chromatography and ultraviolet detection.
    Gwak HS; Noh ES; Lee NY; Chun IK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):109-13. PubMed ID: 15734149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients.
    Barilero I; Gandia D; Armand JP; Mathieu-Boué A; Ré M; Gouyette A; Chabot GG
    J Chromatogr; 1992 Mar; 575(2):275-80. PubMed ID: 1629304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic determination of MEN 935 in human plasma, a highly specific and sensitive analytical method for a new antihypertensive drug.
    Wiedemann I
    Arzneimittelforschung; 1983; 33(6):861-4. PubMed ID: 6684441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput quantification of 8 antihypertensive drugs and active metabolites in human plasma using UPLC-MS/MS.
    van der Nagel BCH; Versmissen J; Bahmany S; van Gelder T; Koch BCP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():367-373. PubMed ID: 28666228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous ultraperformance liquid chromatography/tandem mass spectrometry determination of four antihypertensive drugs in human plasma using hydrophilic-lipophilic balanced reversed-phase sorbents sample preparation protocol.
    Mahrouse MA
    Biomed Chromatogr; 2018 Dec; 32(12):e4362. PubMed ID: 30109716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined derivatization and high-performance liquid chromatography with fluorescence and ultraviolet detection for simultaneous analysis of octreotide and gabexate mesylate metabolite in human pancreatic juice samples.
    Carlucci G; Selvaggi F; Sulpizio S; Bassi C; Carlucci M; Cotellese R; Ferrone V; Innocenti P; Locatelli M
    Biomed Chromatogr; 2015 Jun; 29(6):911-7. PubMed ID: 25354693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.
    Spreux-Varoquaux O; Doll J; Dutot C; Grandjean N; Cordonnier P; Pays M; Andrieu J; Advenier C
    Br J Clin Pharmacol; 1991 Sep; 32(3):399-401. PubMed ID: 1777378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of trandolapril and its metabolite trandolaprilat in human plasma by liquid chromatography/tandem mass spectrometry using solid-phase extraction.
    Nirogi RV; Kandikere VN; Shrivastava W; Mudigonda K
    Rapid Commun Mass Spectrom; 2006; 20(24):3709-16. PubMed ID: 17117442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.
    Messin R; Fenyvesi T; Carreer-Bruhwyler F; Crommen J; Chiap P; Hubert P; Dubois C; Famaey JP; Géczy J
    Eur J Clin Pharmacol; 2003 Jul; 59(3):227-32. PubMed ID: 12734607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of molsidomine in plasma by high-performance liquid column chromatography.
    Dell D; Chamberlain J
    J Chromatogr; 1978 Nov; 146(3):465-73. PubMed ID: 757963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
    J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of cadralazine in human whole blood using reversed-phase high-performance liquid chromatography: utilizing a salting-out extraction procedure.
    Rustum AM
    J Chromatogr; 1989 Apr; 489(2):345-52. PubMed ID: 2753958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic assay for cinnarizine in human plasma.
    Nowacka-Krukowska H; Rakowska M; Neubart K; Kobylińska M
    Acta Pol Pharm; 2007; 64(5):407-11. PubMed ID: 18540159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of linsidomine (SIN 1) after single and multiple intravenous short infusions in patients with renal insufficiency.
    Sennesael J; Verbeelen D; Degré S; Unger P; Stolear JC; Ostrowski J; von Hattingberg HM; Gaertner W
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):533-41. PubMed ID: 8294165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of bufuralol and its major metabolites in plasma by high-performance liquid chromatography.
    Haefelfinger P
    J Chromatogr; 1980 Dec; 221(2):327-35. PubMed ID: 7217302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of talinolol in rat plasma by LC-MS-MS.
    Li Y; Shirasaka Y; Langguth P; Tamai I
    J Chromatogr Sci; 2010; 48(5):367-70. PubMed ID: 20515530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.